共 14 条
- [1] Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in Parkinson’s disease. Contin M,Riva R,Martinelli P,Cortelli P,Albani F,Baruzzi A. Clinical Neurophysiology . 2000
- [2] Pharmacokinetics of Levodopa/Carbidopa Microtablets Versus Levodopa/Benserazide and Levodopa/Carbidopa in Healthy Volunteers. Dag Nyholm,Tommy Lewander,Cecilia Gomes-Trolin. Clinical Neurophysiology . 2012
- [3] Evolving Classifiers to Recognize the Movement Characteristics of Parkinson’’s Disease Patients. Lones M.A,Smith S.L,Alty J.E.etal. IEEE Transactions on Evolutionary Computation . 2014
- [5] A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease. NAGATA T,SHINAGAWA S,TAGAI K,et al. International Psychogeriatrics IPA . 2013
- [6] Using partial decision trees to predict Parkinson’s symptoms: A new approach for diagnosis and therapy in patients suffering from Parkinson’s disease[J] . Themis P. Exarchos,Alexandros T. Tzallas,Dina Baga,Dimitra Chaloglou,Dimitrios I. Fotiadis,Sofia Tsouli,Maria Diakou,Spyros Konitsiotis.  Computers in Biology and Medicine . 2011 (2)
- [7] Mirtazapine improves visual hallucinations in P arkinson’s disease: a case report[J] . Kenji Tagai,Tomoyuki Nagata,Shunichiro Shinagawa,Norifumi Tsuno,Motohiro Ozone,Kazuhiko Nakayama.  Psychogeriatrics . 2013 (2)
- [8] Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson’s disease[J] . C. Marin,M. Bonastre,G. Mengod,R. Cortés,M.C. Rodríguez-Oroz,J.A. Obeso.  Experimental Neurology . 2013